Partial restoration of pre‐transformation levels of lysyl oxidase and transin mRNAs in phenotypic ras revertants
- 1 April 1995
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 12 (4), 198-204
- https://doi.org/10.1002/mc.2940120404
Abstract
Neoplastic transformation mediated by ras oncogenes is associated with deregulated expression of genes encoding, for example, various proteases, lysyl oxidase, and smooth-muscle α-actin. To define the role of these genes in the initiation or maintenance of the ras-transformed state, we compared their steady-state mRNA levels in two different sets of preneoplastic fibroblast lines, ras-transformed clones, and phenotypic revertants derived from them. Compared with the preneoplastic fibroblasts, the ras-transformed derivatives exhibited elevated levels of cathepsin L (major excreted protein), transin (stromelysin I, matrix metalloproteinase–3), and collagenase I (matrix metalloproteinase–1) mRNA but undetectable levels of lysyl oxidase mRNA. Partial restoration of lysyl oxidase transcription was observed in four of five phenotypic revertants derived from rat FE-8 and NIHpEJcI3 cells. The elevated levels of transin mRNA found in NIHpEJcI3 cells were diminished to the pretransformation level in interferon revertants but were not reduced in phenotypic rat FE-8 revertants expressing a high level of the ras oncoprotein. High steady-state levels of collagenase I mRNA were dependent on ras expression but were not closely associated with the transformed phenotype. High levels of cathepsin L mRNA were associated with neither high ras expression nor neoplastic transformation. The downregulation of smooth-muscle α-actin, characteristic of transformed cell lines, was not reversible in phenotypic revertants. © 1995 Wiley-Liss Inc.Keywords
This publication has 38 references indexed in Scilit:
- Expression of stromelysin‐1 and timp‐1 in the involuting mammary gland and in early invasive tumors of the mouseInternational Journal of Cancer, 1994
- Suppression of ras oncogene-mediated transformationReviews of physiology, biochemistry and pharmacology, 1993
- How receptors turn Ras onNature, 1993
- Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras‐transformed NIH 3T3 cellsMolecular Carcinogenesis, 1992
- Human and rat malignant-tumor-associated mRNAs encode stromelysin-like metalloproteinasesBiochemistry, 1989
- Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol estersCell, 1988
- ras GENESAnnual Review of Biochemistry, 1987
- Smooth muscle α-actin is a transformation-sensitive marker for mouse NIH 3T3 and Rat-2 cellsNature, 1985
- Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomasNature, 1983
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976